Public Risk-Taking and Rewards During the COVID-19 Pandemic - A Case Study of Remdesivir in the Context of Global Health Equity
Public investment, through both research grants and university funding, plays a crucial role in the research and development (R&D) of novel health technologies, including diagnostics, therapies, and vaccines, to address the coronavirus disease 2019 (COVID-19) pandemic. Using the example of remde...
Main Authors: | Sabrina Wimmer, Sarai M. Keestra |
---|---|
Format: | Article |
Language: | English |
Published: |
Kerman University of Medical Sciences
2022-05-01
|
Series: | International Journal of Health Policy and Management |
Subjects: | |
Online Access: | https://www.ijhpm.com/article_3909_780e01aa6dcbfc7bf8c2ae19eb02ee58.pdf |
Similar Items
-
The use of remdesivir outside of clinical trials during the COVID-19 pandemic
by: Vesa Halimi, et al.
Published: (2020-12-01) -
INNOVATIVE CHANGES OF VALUES OF THE PUBLIC SECTOR IN THE CONTEXT OF UKRAINE’S EUROPEAN CHOICE
by: Valerii Osetskyi, et al.
Published: (2017-04-01) -
E-learning for student support, inclusion and equity in diverse post-pandemic teaching contexts
by: Margaret Funke Omidire, et al.
Published: (2022-05-01) -
Universal Access to Healthcare: The Case of South Africa in the Comparative Global Context of the Late Anthropocene Era
by: Solomon Benatar, et al.
Published: (2021-02-01) -
Behavioural Feature Extraction For
Context-Aware Traffic Classification
Of Mobile Applications
by: Aun, Yichiet
Published: (2018)